Mesoblast rattles tin for at least $37m with Bell Potter
MELBOURNE: Mesoblast, the local biotech developing treatments for cardiovascular disease and back pain, is no
MELBOURNE: Mesoblast, the local biotech developing treatments for cardiovascular disease and back pain, is no
FEATURED
Construction loan now secured for innovative seniors community
Senior living operators plan more moderate rental rate growth
10-storey apartments under 1500-home plan around golf course
High rise living above casino pitched to boomer market
Pilot study to improve staff interactions with residents with dementia
Senior living marketing leaps into digital age with innovations
INNOVATION
